Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

Natco Pharma Ltd share price was up by 0.06% from the previous closing price of ₹1,173.85. Who are peers of Natco Pharma Ltd? The peers of Natco Pharma Ltd are Sun Pharmaceuticals Industries Ltd ...

Natco Pharma has received US FDA approval for its generic version of Everolimus tablets for oral suspension, indicated for ...

Natco Pharma Ltd (BOM:524816) reports a 35.3% revenue increase and 83% profit growth, while navigating future market uncertainties and regulatory challenges.

Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...

The company was ensured that the sale of the land and building did not constitute part of its operational assets so that the sale will, in no way, impact the company's business operations ...

Order passed by Assistant Commissioner, central Goods & Services Tax Division, Dehradun. Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered ...

NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.

Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...